Literature DB >> 6218262

Digestion and absorption of NAD by the small intestine of the rat.

C J Gross, L M Henderson.   

Abstract

A number of preparations of varying complexity have been used in an effort to elucidate the reactions by which NAD is hydrolyzed to nicotinamide during intestinal digestion. NAD labeled with 14C in the adenine or pyridine moiety was the substrate used with perfused rat intestine, live rats, perfused live rats, with collection of portal flow, intestinal contents, mucosal tissue, or pancreatic juice. The conclusions reached are that a pyrophosphatase present in the intestinal juice and to a much lesser extent in the pancreatic juice releases 5'-AMP and nicotinamide ribonucleotide. The 5'-AMP was rapidly converted to adenosine then to inosine by bacteria-free intestinal contents. Perfused or intact intestine rapidly hydrolyzed NMN to nicotinamide riboside, which accumulated, but was not absorbed. It was slowly cleaved by an enzyme associated with the mucosal cells to nicotinamide, which was the major if not the only labeled compound absorbed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6218262     DOI: 10.1093/jn/113.2.412

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  11 in total

Review 1.  Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?

Authors:  Carles Cantó; Johan Auwerx
Journal:  Pharmacol Rev       Date:  2011-11-21       Impact factor: 25.468

Review 2.  NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus.

Authors:  Carles Cantó; Keir J Menzies; Johan Auwerx
Journal:  Cell Metab       Date:  2015-06-25       Impact factor: 27.287

3.  Cellular Compartmentation and the Redox/Nonredox Functions of NAD.

Authors:  Chaitanya A Kulkarni; Paul S Brookes
Journal:  Antioxid Redox Signal       Date:  2019-03-26       Impact factor: 8.401

4.  Improvement of tissue-specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol.

Authors:  Long-Bo Bai; Lee-Fong Yau; Tian-Tian Tong; Wai-Him Chan; Wei Zhang; Zhi-Hong Jiang
Journal:  Pharmacol Res Perspect       Date:  2022-08

5.  Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity.

Authors:  Hong Yao; Minghui Liu; Leibo Wang; Yumeng Zu; Chou Wu; Chenyu Li; Ruoxi Zhang; Haigen Lu; Feifei Li; Shuang Xi; Shuangquan Chen; Xuanyu Gu; Tianya Liu; Jie Cai; Shirong Wang; Maojun Yang; Guo-Gang Xing; Wei Xiong; Lan Hua; Yefeng Tang; Gelin Wang
Journal:  Cell Res       Date:  2022-04-22       Impact factor: 46.297

6.  Effects of a wide range of dietary nicotinamide riboside (NR) concentrations on metabolic flexibility and white adipose tissue (WAT) of mice fed a mildly obesogenic diet.

Authors:  Wenbiao Shi; Maria A Hegeman; Dorien A M van Dartel; Jing Tang; Manuel Suarez; Hans Swarts; Bart van der Hee; Lluis Arola; Jaap Keijer
Journal:  Mol Nutr Food Res       Date:  2017-04-13       Impact factor: 5.914

Review 7.  Metabolic Therapy of Heart Failure: Is There a Future for B Vitamins?

Authors:  Jérôme Piquereau; Solène E Boitard; Renée Ventura-Clapier; Mathias Mericskay
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 8.  Pharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors.

Authors:  Jing She; Rui Sheng; Zheng-Hong Qin
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

Review 9.  NAD+ Precursors: A Questionable Redundancy.

Authors:  Carles Canto
Journal:  Metabolites       Date:  2022-07-09

10.  Nicotinamide riboside relieves paclitaxel-induced peripheral neuropathy and enhances suppression of tumor growth in tumor-bearing rats.

Authors:  Marta V Hamity; Stephanie R White; Christopher Blum; Katherine N Gibson-Corley; Donna L Hammond
Journal:  Pain       Date:  2020-10       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.